4-(((2-Chloro-8-methylquinolin-3-yl)methylene)amino)-3-thioxo-6-(3,4,5-trimethoxybenzyl)-3,4-dihydro-1,2,4-triazin-5(2H)-one

ID: ALA4876637

PubChem CID: 164627037

Max Phase: Preclinical

Molecular Formula: C24H22ClN5O4S

Molecular Weight: 511.99

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1cc(Cc2n[nH]c(=S)n(/N=C/c3cc4cccc(C)c4nc3Cl)c2=O)cc(OC)c1OC

Standard InChI:  InChI=1S/C24H22ClN5O4S/c1-13-6-5-7-15-11-16(22(25)27-20(13)15)12-26-30-23(31)17(28-29-24(30)35)8-14-9-18(32-2)21(34-4)19(10-14)33-3/h5-7,9-12H,8H2,1-4H3,(H,29,35)/b26-12+

Standard InChI Key:  IGMIAAAJLONULO-RPPGKUMJSA-N

Molfile:  

 
     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
   32.6491  -15.8939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6479  -16.7135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3560  -17.1224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3542  -15.4851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0628  -15.8903    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.0636  -16.7093    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7721  -17.1164    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.4804  -16.7056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.4756  -15.8834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7665  -15.4801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1808  -15.4706    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8910  -15.8748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.5962  -15.4619    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.3043  -15.8689    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0074  -15.4595    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.0066  -14.6420    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   38.2966  -14.2355    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.5873  -14.6466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.8771  -14.2425    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   38.3066  -16.6861    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   39.7161  -15.8665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4228  -15.4562    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1273  -15.8648    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8335  -15.4553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.8321  -14.6372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.1185  -14.2304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.4151  -14.6423    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1897  -17.1114    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   41.1137  -13.4133    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   41.8190  -13.0005    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5383  -14.2261    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.2475  -14.6321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.5420  -15.8626    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.5435  -16.6798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.3579  -17.9396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  9 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 13 18  1  0
 14 15  1  0
 15 16  2  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 14 20  2  0
 15 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  8 28  1  0
 26 29  1  0
 29 30  1  0
 25 31  1  0
 31 32  1  0
 24 33  1  0
 33 34  1  0
  3 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4876637

    ---

Associated Targets(Human)

PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PTGS1 Cyclooxygenase-1 (5266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RAW264.7 (28094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 511.99Molecular Weight (Monoisotopic): 511.1081AlogP: 4.31#Rotatable Bonds: 7
Polar Surface Area: 103.62Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 7.36CX Basic pKa: 0.03CX LogP: 5.02CX LogD: 4.75
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.22Np Likeness Score: -1.14

References

1. Ghanim AM, Rezq S, Ibrahim TS, Romero DG, Kothayer H..  (2021)  Novel 1,2,4-triazine-quinoline hybrids: The privileged scaffolds as potent multi-target inhibitors of LPS-induced inflammatory response via dual COX-2 and 15-LOX inhibition.,  219  [PMID:33892270] [10.1016/j.ejmech.2021.113457]

Source